First National Trust’s Boston Scientific BSX Stock Holding History

First National Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.06M	Sell	112,477 -3,693	-3%	-$295K	0.24%	95
2025 Q4	$11.1M	Buy	116,170 +1,364	+1%	+$134K	0.37%	60
2025 Q3	$11.2M	Buy	114,806 +2,504	+2%	+$259K	0.38%	62
2025 Q2	$12.1M	Sell	112,302 -2,704	-2%	-$274K	0.45%	55
2025 Q1	$11.6M	Sell	115,006 -5,604	-5%	-$564K	0.47%	55
2024 Q4	$10.8M	Sell	120,610 -2,311	-2%	-$203K	0.4%	61
2024 Q3	$10.3M	Sell	122,921 -289	-0.2%	-$22.8K	0.4%	60
2024 Q2	$9.49M	Sell	123,210 -9,827	-7%	-$719K	0.39%	59
2024 Q1	$9.11M	Sell	133,037 -100,262	-43%	-$6.45M	0.37%	67
2023 Q4	$13.5M	Sell	233,299 -29,779	-11%	-$1.59M	0.59%	47
2023 Q3	$13.9M	Buy	263,078 +7,645	+3%	+$401K	0.66%	43
2023 Q2	$13.8M	Buy	255,433 +5,091	+2%	+$266K	0.64%	44
2023 Q1	$12.5M	Sell	250,342 -356	-0.1%	-$16.8K	0.67%	45
2022 Q4	$11.6M	Buy	250,698 +5,304	+2%	+$230K	0.61%	51
2022 Q3	$9.51M	Buy	245,394 +11,474	+5%	+$460K	0.55%	57
2022 Q2	$8.72M	Buy	233,920 +17,639	+8%	+$718K	0.49%	62
2022 Q1	$9.58M	Buy	216,281 +33,081	+18%	+$1.43M	0.5%	66
2021 Q4	$7.78M	Buy	+183,200	New	+$7.7M	0.41%	80

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First National Trust's BSX Position: Q1 2026 in Review

First National Trust reduced its Boston Scientific (BSX) stake by 3.2% in Q1 2026, selling an estimated $295K and leaving 112,477 shares worth $7.06M. The position accounts for 0.24% of the portfolio, ranked #95.

First National Trust first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.9M in Q3 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

First National Trust held 112,477 shares of Boston Scientific worth $7.06M as of Q1 2026.
First National Trust sold 3,693 Boston Scientific shares in Q1 2026, an estimated $295K.
Boston Scientific made up 0.24% of First National Trust's portfolio in Q1 2026, its #95 holding.
First National Trust first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
First National Trust's Boston Scientific position peaked at $13.9M in Q3 2023.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.